Please assess the completion status of the following clinical trial:

Trial Title: Measurement of Midazolam Levels in Follicular Fluid

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infertility (prim. / sec.)~* Age \>18 - ≤ 38 years.~* BMI 19-30~* Stimulation in GnRH-antagonist protocol, using rFSH~* Expected normal ovarian response (6)~* At least 4 follicles with the size ≥ than 17 mm on the day of OPU~* Patients undergoing PGS~* Able to understand the aim of the study and to provide consent~Exclusion Criteria:~* History of endometriosis, classified according to the American Fertility Society (AFS) as stage 3 or more.~* Severe male factor

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- Control group using Propofol (Type: NO_INTERVENTION): Sedation will be established by administering 100mcs of Fentanyl, and 1-1.5mg/kg of body weight of Propofol.
- Study group Midazolam group (Type: EXPERIMENTAL): Sedation will be established by administering Midazolam 1mg, 100mcs of Fentanyl, and 0.5-1mg/kg of body weight of Propofol. Further boluses of Propofol will be given according to the need of the patient and time consumed for oocyte retrieval.

Based on this trial design, predict the completion outcome and termination type (if applicable).